Superiority of high-dose cytarabine-based mobilisation over cyclophosphamide or plerixafor in primary CNS lymphoma. - Li Q; Zhu L; Ma Y; Ma J; Zhang M; Lin Z; Chen B (Annals of hematology, 2026)